Here are the latest quarterly results of AARTI DRUGS. For more details, see the AARTI DRUGS financial fact sheet and AARTI DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6,943 | 6,220 | 6,877 | 6,640 | 7,424 | 6,611 | 6,415 | 6,059 | |
Other income | Rs m | 30 | 3 | 1 | 10 | 9 | 6 | 7 | 17 | |
Turnover | Rs m | 6,972 | 6,222 | 6,878 | 6,650 | 7,433 | 6,617 | 6,422 | 6,076 | |
Expenses | Rs m | 6,083 | 5,548 | 6,135 | 5,933 | 6,489 | 5,770 | 5,651 | 5,358 | |
Gross profit | Rs m | 860 | 671 | 743 | 707 | 935 | 841 | 765 | 701 | |
Depreciation | Rs m | 126 | 125 | 127 | 126 | 125 | 126 | 126 | 127 | |
Interest | Rs m | 59 | 68 | 85 | 94 | 86 | 85 | 83 | 76 | |
Profit before tax | Rs m | 705 | 480 | 532 | 497 | 733 | 635 | 563 | 516 | |
Tax | Rs m | 152 | 133 | 145 | 130 | 171 | 156 | 167 | 148 | |
Profit after tax | Rs m | 553 | 348 | 387 | 367 | 562 | 480 | 396 | 367 | |
Gross profit margin | % | 12.4 | 10.8 | 10.8 | 10.6 | 12.6 | 12.7 | 11.9 | 11.6 | |
Effective tax rate | % | 21.5 | 27.6 | 27.2 | 26.2 | 23.3 | 24.5 | 29.6 | 28.8 | |
Net profit margin | % | 8.0 | 5.6 | 5.6 | 5.5 | 7.6 | 7.3 | 6.2 | 6.1 | |
Diluted EPS | Rs | 6.0 | 3.8 | 4.2 | 4.0 | 6.1 | 5.2 | 4.3 | 4.0 | |
Diluted EPS (TTM) | Rs | 22.3 | 20.8 | 20.4 | 18.0 | 18.1 | 19.5 | 19.6 | 19.6 | |
Subscriber Feature |
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.